Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Sullivan, S
Right arrow Articles by Poulter, L W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Sullivan, S
Right arrow Articles by Poulter, L W
Thorax 2004;59:657-661
© 2004 BMJ Publishing Group Ltd & British Thoracic Society


ASTHMA

Fluticasone induces T cell apoptosis in the bronchial wall of mild to moderate asthmatics

S O’Sullivan1, L Cormican2, C M Burke2, L W Poulter1

1 Department of Immunology, Royal Free and University College Hospital Medical School, London NW3 2QG, UK
2 Department of Respiratory Medicine, James Connolly Memorial Hospital, Dublin 15, Ireland

Correspondence to:
Correspondence to:
Dr S O’Sullivan
Department of Immunology, Royal Free and University College Hospital Medical School, London NW3 2QG, UK; sioosu{at}indigo.ie

Background: Cytokines which signal via the gamma chain of the interleukin (IL)-2 receptor and the interferons (IFNs) have been shown to enhance T cell survival in vitro by rescuing cells from apoptosis.

Methods: A study was undertaken to determine whether treatment with inhaled fluticasone propionate (FP; 250 µg twice daily) for 2 weeks could modulate production of IL-15 or IFN-ß and thereby affect T cell survival in bronchial tissue of 10 patients with mild/moderate asthma. Bronchial biopsy specimens were taken before and on completion of treatment.

Results: The mean (95% CI) number of T cells per unit area decreased in the asthmatic group following 2 weeks of treatment with FP (from 7.0 (5.6 to 8.4) to 4.5 (4.0 to 5.1); p = 0.001). There was an increase in the percentage of T cells undergoing apoptosis following FP treatment as assessed by T cell/TUNEL staining (from 4.5 (2.6 to 6.4) to 8.7 (6.6 to 10.8); p = 0.0001). The percentage of cells staining for IL-15 and IFN-ß in the lamina propria, determined by an alkaline phosphatase biotin streptavidin technique, decreased significantly from baseline values of 31.6 (23.4 to 39.7) to 19.6 (12.5 to 26.7), p = 0.039 for IL-15 and from 18.9 (13.5 to 24.4) to 9.5 (5.9 to 13.1), p = 0.007 for IFN-ß following 2 weeks of treatment with FP. However, only the decrease in the percentage of cells staining for IL-15 was significantly correlated with an increased number of apoptotic T cells following treatment (p = 0.008).

Conclusion: These findings support a novel mechanism for the ability of inhaled corticosteroids to decrease T cell numbers, possibly by downregulation of the cytokine IL-15.


Keywords: apoptosis; T cells; asthma; fluticasone propionate




This article has been cited by other articles:


Home page
Eur Respir JHome page
T. Kobayashi, Y. Takaku, A. Yokote, H. Miyazawa, T. Soma, K. Hagiwara, M. Kanazawa, and M. Nagata
Interferon-{beta} augments eosinophil adhesion-inducing activity of endothelial cells
Eur. Respir. J., December 1, 2008; 32(6): 1540 - 1547.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. Siddiqui, F. Hollins, S. Saha, and C. E. Brightling
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Eur. Respir. J., December 1, 2007; 30(6): 1043 - 1056.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & British Thoracic Society